Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Fully human Anti-epidermal growth factor receptor antibodies

a technology of growth factor receptor and fully human body, which is applied in the field of fully human antiepidermal growth factor receptor (egfr) antibodies, can solve the problems of poor clinical prognosis and overexpression of egfr

Active Publication Date: 2011-11-17
SAMSUNG ELECTRONICS CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The overexpression of EGFR is known to be related with poor clinical prognosis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fully human Anti-epidermal growth factor receptor antibodies
  • Fully human Anti-epidermal growth factor receptor antibodies
  • Fully human Anti-epidermal growth factor receptor antibodies

Examples

Experimental program
Comparison scheme
Effect test

examples

[0044]Hereinafter, description will be made in more detail through examples. However, the following examples are not intended to be limiting.

[0045]1. Phage Display Libraries

[0046]Phage display libraries (Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea) are used that express on the phage surface over 100 billion variable domains of the heavy chain and light chain of fully human antibodies derived from human blood and bone marrow in the form of single chain variable fragment (scFv).

[0047]2. Antigens

[0048]One antigen used is Erbb1-Fc (Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea), a protein construct in which the first 360 amino acids of human epithelial growth factor receptor (EGFR; NCBI Accession Number: P00533) including the first ligand binding domain and a furin-like repeat are linked with an Fc domain. The Erbb1-Fc is expressed in HEK-293 cells (ATCC, CRL-1573) and purified for use as an antigen. Commercially available human ep...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
compositionaaaaaaaaaa
structureaaaaaaaaaa
Login to View More

Abstract

Disclosed are fully human anti-epidermal growth factor receptor (EGFR) antibodies, fragments thereof, and nucleic acid sequences encoding for the same. Further disclosed are methods of making and using the antibodies.

Description

BACKGROUND[0001]1. Field[0002]Disclosed are fully human anti-epidermal growth factor receptor (EGFR) antibodies, fragments thereof and applications thereof.[0003]2. Description of the Related Art[0004]The development of antibodies has evolved from mouse antibodies, to chimeric antibodies, to humanized antibodies, and to fully human antibodies. Fully human antibodies are advantageous over other types of antibodies in that immune response in humans can be reduced. Thus, recent research is centered on the development of fully human antibodies.[0005]Epidermal growth factor receptor (EGFR; alternatively called Erbb1 or HER1) is a 170-kDa, type 1 transmembrane molecule. Its expression is enhanced in many human tumors, including those in head, neck, breast, colon, prostate gland, lung and ovary. The overexpression of EGFR is known to be related with poor clinical prognosis. Further, expression of EGFR is often accompanied by the production of EGFR ligands, particularly tumor growth factor-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K39/395A61P35/00G01N33/53C12N1/00C12N5/00C12P21/08C07K16/00C12N15/63
CPCC07K16/2863C07K2317/21C07K2317/92C07K2317/76C07K2317/622A61P35/00
Inventor SEO, SANG WONCHO, A. YEONJEONG, SUNG YOUNG
Owner SAMSUNG ELECTRONICS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com